Thu, 14 Feb 2008 16:13:18 -0500 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/InternalMedicineVideoUS/vidInternal_Medicine_CMECE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Internal Medicine no PeerView Press In this activity, cardiology experts in the management of acute coronary syndrome (ACS) describe the rationale and updated guidelines supporting the long-term use of dual antithrombotic therapy in patients who have undergone percutaneous coronary intervention (PCI) with stent placement. In addition, limitations regarding the pharmacokinetics of clopidogrel in this context lay the foundation for the discussion of novel antithrombotic agents in development. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, cardiology experts in the management of acute coronary syndrome (ACS) describe the rationale and updated guidelines supporting the long-term use of dual antithrombotic therapy in patients who have undergone percutaneous coronary intervention (PCI) with stent placement. In addition, limitations regarding the pharmacokinetics of clopidogrel in this context lay the foundation for the discussion of novel antithrombotic agents in development. http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04374FCr371.m4v http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04374FCr371.m4v Fri, 08 Feb 2008 16:51:04 -0500 Science no 00:28:22 Acute coronary syndrome, angioplasty, PCI, clopidogrel, aspirin, stent, paclitaxel-eluting, sirolimus-eluting, bare metal, percutaneous coronary intervention, ticlopidine, prasugrel, thienopyridine, unstable angina, NSTEMI PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/InternalMedicine/PA04374FCCMEinfo.pdf http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04374FCCMEinfo.pdf Fri, 08 Feb 2008 16:50:59 -0500 Science no 00:00:00 Acute coronary syndrome, angioplasty, PCI, clopidogrel, aspirin, stent, paclitaxel-eluting, sirolimus-eluting, bare metal, percutaneous coronary intervention, ticlopidine, prasugrel, thienopyridine, unstable angina, NSTEMI PeerView Press In this CME activity, experts in the management of diabetic neuropathy discuss diagnosis and management of this condition. The efficacy and safety of agents used in the management of diabetic neuropathy are also discussed. Please be sure to view the accompanying (PDF) file for full CME information. In this CME activity, experts in the management of diabetic neuropathy discuss diagnosis and management of this condition. The efficacy and safety of agents used in the management of diabetic neuropathy are also discussed. http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA014027FCr339.m4v http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04027FCr339.m4v Mon, 26 Nov 2007 09:30:14 -0500 Science & Medicine no 00:19:13 Diabetes, diabetes mellitus, neuropathy, peripheral neuropathy, neuropathic pain, antiepileptic agents, antidepressants, opioids, pregabalin, duloxetine, tricyclic antidepressants, amitriptyline, desipramine, gabapentin, carbamazepine PeerView Press Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04027FCCMEinfo.pdf http://podcast.peerviewpress.com/InternalMedicineVideoUS/PA04027FCCMEinfo_2.pdf Mon, 26 Nov 2007 09:29:09 -0500 Science & Medicine no 00:00:00 Diabetes, diabetes mellitus, neuropathy, peripheral neuropathy, neuropathic pain, antiepileptic agents, antidepressants, opioids, pregabalin, duloxetine, tricyclic antidepressants, amitriptyline, desipramine, gabapentin, carbamazepine PeerView Press In this activity, expert physicians discuss the prevalence of PAD and its significance as a predictor of major vascular events. Data regarding use of the ankle-brachial index (ABI) to screen for PAD in at-risk patients is presented, as well as management strategies for reducing the risk of associated major vascular events, such as MI, stroke, and vascular death. Please be sure to view the accompanying (PDF) file for full CME information. In this activity, expert physicians discuss the prevalence of PAD and its significance as a predictor of major vascular events. Data regarding use of the ankle-brachial index (ABI) to screen for PAD in at-risk patients is presented, as well as management strategies for reducing the risk of associated major vascular events, such as MI, stroke, and vascular death. http://podcast.peerviewpress.com/InternalMedicineVideoUS/PI03648FCr298.m4v http://podcast.peerviewpress.com/InternalMedicineVideoUS/PI03648FCr298.m4v Thu, 10 May 2007 10:55:07 -0400 Science & Medicine no 00:27:45 Ankle-brachial index (ABI), Aspirin, Claudication, Clopidogrel, Peripheral Arterial Disease Detection, Awareness, and Treatment: New Resources for Survival (PARTNERS), Peripheral artery disease (PAD) PeerView Press Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/InternalMedicineVideoUS/PI03648FCCMEinfo.pdf http://podcast.peerviewpress.com/InternalMedicineVideoUS/PI03648FCCMEinfo.pdf Thu, 10 May 2007 10:54:55 -0400 Science & Medicine no 00:00:00 Ankle-brachial index (ABI), Aspirin, Claudication, Clopidogrel, Peripheral Arterial Disease Detection, Awareness, and Treatment: New Resources for Survival (PARTNERS), Peripheral artery disease (PAD)